Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States
Avicanna LATAM SAS (OTC:AVCNF) has partnered with Harrington Wellness to launch re+PLAY CBD wellness brand topicals across the United States. The collaboration introduces two initial products: a 3% CBD localized cream and a 2% CBD and 1% CBG transdermal gel utilizing Avicanna's patented deep tissue technology.
The products, developed through collaboration between scientists, athletes, doctors, and certified athletic trainers, will be available through replaycbd.com and select U.S. retailers in September 2025. The CBD and CBG ingredients are sourced from USDA organic certified hemp cultivated by Avicanna's subsidiary Santa Marta Golden Hemp and manufactured in Colombia.
Avicanna LATAM SAS (OTC:AVCNF) ha siglato una partnership con Harrington Wellness per lanciare la linea di topici re+PLAY CBD wellness brand negli Stati Uniti. La collaborazione presenta due prodotti iniziali: una crema localizzata al 3% di CBD e un gel transdermico con 2% di CBD e 1% di CBG, entrambi basati sulla tecnologia brevettata di penetrazione profonda di Avicanna.
I prodotti, sviluppati con il contributo di scienziati, atleti, medici e preparatori atletici certificati, saranno disponibili su replaycbd.com e presso rivenditori selezionati negli USA a partire da settembre 2025. Gli ingredienti a base di CBD e CBG provengono da canapa certificata USDA organic coltivata dalla controllata di Avicanna, Santa Marta Golden Hemp, e sono prodotti in Colombia.
Avicanna LATAM SAS (OTC:AVCNF) se ha asociado con Harrington Wellness para lanzar los tópicos de la marca re+PLAY CBD wellness brand en Estados Unidos. La colaboración presenta dos productos iniciales: una crema localizada con 3% de CBD y un gel transdérmico con 2% de CBD y 1% de CBG, que emplean la tecnología patentada de Avicanna para penetración en tejido profundo.
Desarrollados por científicos, atletas, médicos y entrenadores atléticos certificados, los productos estarán disponibles en replaycbd.com y en minoristas selectos de EE. UU. en septiembre de 2025. Los ingredientes de CBD y CBG provienen de cáñamo certificado USDA organic cultivado por la filial Santa Marta Golden Hemp de Avicanna y se fabrican en Colombia.
Avicanna LATAM SAS (OTC:AVCNF)는 Harrington Wellness와 협력해 미국 전역에 re+PLAY CBD wellness brand 토피칼 제품을 출시합니다. 이번 협업으로 선보이는 첫 제품은 3% CBD 국소 크림과 2% CBD 및 1% CBG 성분의 경피용 젤로, Avicanna의 특허받은 심부 조직 침투 기술을 적용했습니다.
과학자, 선수, 의사 및 공인 운동 재활 트레이너들이 함께 개발한 이 제품들은 2025년 9월부터 replaycbd.com과 미국 내 일부 소매점에서 구매할 수 있습니다. CBD 및 CBG 성분은 Avicanna의 자회사 Santa Marta Golden Hemp가 재배한 USDA 유기 인증 헴프에서 공급되며, 생산은 콜롬비아에서 이루어집니다.
Avicanna LATAM SAS (OTC:AVCNF) s'est associé à Harrington Wellness pour lancer les topiques de la marque re+PLAY CBD wellness brand aux États-Unis. La collaboration présente deux produits initiaux : une crème localisée à 3% de CBD et un gel transdermique à 2% de CBD et 1% de CBG, utilisant la technologie brevetée d'Avicanna pour une pénétration profonde des tissus.
Développés par des scientifiques, des athlètes, des médecins et des entraîneurs certifiés, les produits seront disponibles sur replaycbd.com et chez certains détaillants américains à partir de septembre 2025. Les ingrédients CBD et CBG proviennent du chanvre certifié USDA organic cultivé par la filiale Santa Marta Golden Hemp d'Avicanna et sont fabriqués en Colombie.
Avicanna LATAM SAS (OTC:AVCNF) hat eine Partnerschaft mit Harrington Wellness geschlossen, um die topischen Produkte der Marke re+PLAY CBD wellness brand in den USA einzuführen. Die Zusammenarbeit startet mit zwei Produkten: einer lokalen Creme mit 3% CBD und einem transdermalen Gel mit 2% CBD und 1% CBG, die Avicannas patentierte Deep-Tissue-Technologie nutzen.
Die Produkte wurden von Wissenschaftlern, Athleten, Ärzten und zertifizierten Athletic Trainern entwickelt und sind ab September 2025 über replaycbd.com sowie ausgewählte Einzelhändler in den USA erhältlich. Die CBD- und CBG-Inhaltsstoffe stammen aus USDA-Organic-zertifiziertem Hanf, der von Avicannas Tochtergesellschaft Santa Marta Golden Hemp angebaut und in Kolumbien hergestellt wird.
- Partnership with NBA veteran Al Harrington's Harrington Wellness expands U.S. market presence
- Products utilize proprietary and patented drug delivery systems
- USDA organic certification for hemp-derived ingredients
- Nationwide distribution through online and retail channels
- Limited initial product line with only two offerings
- Dependence on third-party retailers for distribution
re+PLAY is a CBD wellness brand founded by NBA veteran Al Harrington with products utilizing Avicanna’s patented and proprietary CBD formulations.
The initial launch of re+PLAY in the United States includes two products available at Harrington Wellness’ replaycbd.com as well as select retailers across the United States in September.
SANTA MARTA, Colombia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Avicanna LATAM SAS is an international biopharmaceutical company based in Colombia and focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. Avicanna LATAM SAS, a wholly owned subsidiary of Avicanna Inc., is pleased to announce the launch of the re+PLAY CBD wellness brand with Harrington Wellness nationwide across the United States.
re+PLAY is a CBD wellness brand built with collaborative effort from scientists, athletes, doctors, and certified athletic trainers. Avicanna LATAM SAS and Harrington Wellness have collaborated over several years on the research and development of these CBD-based topicals inspired by the athletic and sports community. These CBD-based topicals utilize Avicanna’s proprietary and drug delivery systems, organic hemp derived cannabinoids and international manufacturing with the support of Harrington Wellness’ deep understanding of professional athletes and their needs.
“As a business executive and former professional athlete, I’m proud to expand our collaboration with Avicanna to introduce this unique and scientifically backed line of CBD wellness products to the United States,” stated Al Harrington, CEO of Harrington Wellness.
Initial product offerings include a
About Avicanna
Avicanna LATAM SAS, a wholly owned subsidiary of Avicanna Inc., is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Avicanna LATAM SAS and Avicanna Inc. have an established scientific platform including R&D and clinical development leading to the commercialization around the world of more than thirty proprietary, evidence-based finished products and supporting four commercial stage business pillars.
- Medical Cannabis formulary (RHO Phyto™): The formulary offers a diverse range of proprietary products including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids, supported by ongoing patient and medical community education. RHO Phyto™ products are not available in the US.
- Medical cannabis care platform (MyMedi.ca): In Canada, Avicanna LATAM SAS’s subsidiary Avicanna Inc. owns MyMedi.ca, which is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the medical cannabis patients’ journey. MyMedi.ca is operated by Northern Green Canada Inc. and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. MyMedi.ca is not intended for US audiences, and products are not available to those that reside in the US
- Pharmaceutical pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna LATAM SAS has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development in Latin America and elsewhere around the world.
- Active pharmaceutical ingredients (Aureus Santa Marta™): Active pharmaceutical ingredients supplied by Avicanna LATAM SAS’s subsidiary Santa Marta Golden Hemp SAS (“SMGH”) is a commercial-stage business dedicated to providing various forms of high-quality CBD, THC and CBG to Avicanna LATAM SAS’s international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products. SMGH also forms part of the Avicanna’s global supply chain and is a source of reliable input products for its consumer retail, medical cannabis, and pharmaceutical products globally.
SOURCE Avicanna LATAM SAS.
About re+PLAY
re+PLAY is a performance-based CBD wellness brand that delivers the natural effects of CBD through formulations that have undergone research and development to meet the standards demanded by athletes and physicians. The re+PLAY line of products is THC-free and has been endorsed and used variously by doctors, professional athletes, and certified athletic trainers. re+PLAY was founded by NBA veteran Al Harrington, trainer Joe Abunasser, and Dr. Sanford Kunkel the previous team physician for the Indiana Pacers and the USA National Basketball Team.
SOURCE Harrington Wellness
NOTE: THESE PRODUCTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASES OR CONDITIONS OR ANY BODILY FUNCTIONS. THE EFFICACY OF THESE PRODUCTS HAS NOT BEEN CONFIRMED BY FDA-APPROVED RESEARCH. THESE PRODUCTS SHOULD NOT BE USED IF YOU ARE PREGNANT OR NURSING. CONSULT A PHYSICIAN BEFORE USE IF YOU HAVE ANY MEDICAL CONDITIONS OR USE PRESCRIPTION MEDICATION.
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this news release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions. Although the Avicanna LATAM SAS believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Avicanna LATAM SAS (and Avicanna LATAM SAS’s parent company, Avicanna Inc.) can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of Avicanna Inc., and the risk factors set out in the Avicanna Inc.’s annual information form dated April 11, 2025, filed with the Canadian securities regulators and available under the Avicanna Inc.’s profile on SEDAR+ at www.sedarplus.ca. The statements in this news release are made as of the date of this release. Avicanna LATAM SAS, Avicanna Inc., together with its subsidiaries and affiliates disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Stay Connected
For more information about Avicanna, visit our website or contact Ivana Maric by email at info@avicanna.com.
FAQ
What products is Avicanna (AVCNF) launching with re+PLAY in the United States?
When will re+PLAY CBD products be available in the United States?
Who is behind the re+PLAY CBD wellness brand?
Where are re+PLAY's CBD products manufactured?
How can investors purchase re+PLAY CBD products?
